ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 227

Quantitative Image Analysis Of Articular Involvement In Blau Syndrome By Radiographic Calpal Length and Ultrasound Assessment

Tsuyoshi Yamatou1, Tomohiro Kubota2, Harumi Akaike1, Yuichi Yamasaki2, Yukiko Nonaka1, Yasuhito Nerome1, Tomoko Takezaki1, Hiroyuki Imanaka1, Kei Ikeda3, Naotomo Kambe4, Syuji Takei5 and Tomokazu Nagakura6, 1Department of Pediatrics, Kagoshima University Hospital, Kagoshima, Japan, 2Dept of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan, 3Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan, 4Dermatology, Chiba University Graduate School of Medicine, Chiba, Japan, 5School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan, 6Department of Pediatrics, House of Meguminoseibo, Usuki, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Autoinflammatory Disease, Blau syndrome, joint damage, radiography and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases I: Imaging in Gout, Pediatric, Soft and Connective Tissue Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Blau syndrome (Blau) is a rare auto-inflammatory disease, and it has now been shown to be caused by NOD2/CARD15 gene mutations. Clinical features of Blau consist of granulomatous inflammation in the joints, eyes, and skin. However, most of the patients were initially miss-diagnosed as JIA because the symmetrical polyarthritis occurred in early phase of the disease, and “boutonniere” deformities-like fingers appeared during the disease course. However, the articular involvement in Blau has been considered as non-erosive. Therefore, we evaluate the joint damage in Blau patients by measuring calpal length (CL), an objective tool for evaluating cartilage damage in polyariticular JIA (poJIA)1-2).

 

Methods: A total of 6 Blau patients were followed up their CL for mean 9.2 years. Their disease duration at the first CL measurement was 5.2 years. Since biologic agents were used in 5 of 6 of the Blau patients, changes in CL of 46 poJIA patients treated with biologics were also followed up. CL was analyzed by standard deviation (SD) calculated by Poznanski’s formula established from healthy children3).

In addition, ultrasound examination was carried out in 4 Blau patients at the last observation. A total of 3 joints and 4 tenosynovial sites in the wrist were scanned and the ultrasound images of gray-scale (GS) or Power Doppler (PD) findings were graded from 0 (normal) to 3 (severe).

 

Results: Though all Blau patients had comptodactyly with “boutonniere” deformities like fingers, CL(SD) maintained normal range (within – 2SD to +2SD) during the observation period regardless of biologic therapy (Figure 1). On the contrary, CL(SD) in poJIA decreased with disease course especially before initiating biologic therapy, and there were negative correlation between the CL(SD) and the disease duration in both RF positive (p=0.0018) and RF negative (p=0.008) poJIA patients.

Ultrasound examination revealed that tenosynovitis was more frequent and severe than intra-articular synovitis in the 8 wrists of 4 Blau patients; Grade 1-3 findings were found in 62.5% by PD and 31.2% by GS in scanned tenosynovium sites, while it was 29.2% by PD and 4.2% by GS in intra-articular synovium sites (tendon vs intra-articular sites: p=0.0169 by PD, p=0.0161 by GS).

Conclusion: Comptodactyly with “boutonniere” deformities-like findings, a characteristic feature of Blau, may be caused by tenosynovitis but not by cartilage destruction in finger joints. The finding indicates the usefulness of CL and ultrasound examination in differentiating Blau from JIA, and is also suggestive that tenosynovitis may be more predominant than intra-articular synovitis in Blau syndrome.

 

1) Ravelli A, et al. J Pediatr 1998; 133:262-5. 2) Kubota T et al. #1163, 2012 ACR Annual Meeting. 3) Poznanski AK et al. Radiology 1978;129:661-8.

 


Disclosure:

T. Yamatou,
None;

T. Kubota,
None;

H. Akaike,
None;

Y. Yamasaki,
None;

Y. Nonaka,
None;

Y. Nerome,
None;

T. Takezaki,
None;

H. Imanaka,
None;

K. Ikeda,
None;

N. Kambe,
None;

S. Takei,

Chugai, Eisai, Takeda, and Bristol-Myers,

2,

Chugai, Eisai, Takeda, Abbvie, Astellas, Teijin, Novartis, Pfizer, and Asahi Kasei,

8;

T. Nagakura,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-image-analysis-of-articular-involvement-in-blau-syndrome-by-radiographic-calpal-length-and-ultrasound-assessment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology